Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial

Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial

Introduction: This study was performed to evaluate the degree of 3-day chemotherapy-induced nausea and vomiting (CINV) in children with cancer who received highly emetogenic chemotherapy (HEC) to ascertain the efficacy of aprepitant single-dose on dayL 1 plus granisetron and dexamethasone (DEX). Met...

Full description

Bibliographic Details
Main Authors: Aziz Eghbali, Fatemeh Khazaei Kohpar, Kazem Ghaffari, Roghayeh Rahimi Afzal, Aygin Eghbali, Ali Ghasemi
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Aprepitant
Dexamethasone
Granisetron
Nausea
Vomiting
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137922000414

Internet

http://www.sciencedirect.com/science/article/pii/S2531137922000414

Similar Items